Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top

Clinical & Experimental Metastasis

Issue 3/2003

Content (10 Articles)

Introduction

Danny R. Welch, Ann F. Chambers

Genetic alterations responsible for metastatic phenotypes of lung cancer cells

Jun Yokota, Michiho Nishioka, Masachika Tani, Takashi Kohno

CD44 and its partners in metastasis

Serge Jothy

Integrin adhesion receptors in tumor metastasis

Brunhilde Felding-Habermann

Angiogenesis and the role of epigenetics in metastasis

Brenda L. Coomber, Joanne L. Yu, Kelly E. Fathers, Claire Plumb, Janusz W. Rak

The vascular phenotype of melanoma metastasis

Omaida C. Velazquez, Meenhard Herlyn

The hypoxic tumour microenvironment and metastatic progression

Patrick Subarsky, Richard P. Hill

Transcriptional regulation of metastasis-related genes in human melanoma

Okot Nyormoi, Menashe Bar-Eli

Translational control and metastatic progression: Enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs

Jeremy R. Graff, Stephen G. Zimmer

The skeleton as a unique environment for breast cancer cells

Andrea M. Mastro, Carol V. Gay, Danny R. Welch

Mar 03
Issue: 2/2003
Jul 03
Issue: 4/2003

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits